Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2014 / Cilt: 25 - Sayı: 2

Feto-maternal outcomes of pregnancies with thrombocytopenia

Gebelikte trombositopeni saptanan olguların fetomaternal sonuçları

Pages
89–94
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Primary cesarean ratio was 48.7% (39/80) in thrombocytopenic group, whereas it was 23.75% (19/80) in control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background:To compare the feto-maternal outcomes be tween healthy and thrombocytopenic pregnancies.
📊
Key Findings & Data:Methods:The data of pregnancies with thrombocytopenia (n=80) admitted to our clinic between January 2008-January 2013 are evaluated retrospectively.
💡
Conclusion & Impact:Primary cesarean ratio was 48.7% (39/80) in thrombocytopenic group, whereas it was 23.75% (19/80) in control group (p
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Background:To compare the feto-maternal outcomes be tween healthy and thrombocytopenic pregnancies. Methods:The data of pregnancies with thrombocytopenia (n=80) admitted to our clinic between January 2008-January 2013 are evaluated retrospectively. Data for healthy pregnan cies (n=80) were randomly selected during the same period. Results:The most common cause of thrombocytopenia was gestational thrombocytopenia found in 31 pregnancies. Thir ty-four patients had preeclampsia, 6 patients had eclampsia, 2 patients had HELLP syndrome, and 7 had idiopathic throm bocytopenic purpura (ITP). The mean age was 29.41±5.48 and 29.80±5.98 in thrombocytopenic pregnancies and healthy pregnancies, respectively (p 0.670). Primary cesarean ratio was 48.7% (39/80) in thrombocytopenic group, whereas it was 23.75% (19/80) in control group (p

Özet

Amaç:Gebelikte trombositopeni saptanan olguların fetal ve maternal sonuçlarının sağlıklı gebelikler ile karşılaştırılması. Gereç ve Yöntem: Ocak 2008-Ocak 2013 tarihleri arasında kliniğimizde takip edilmiş trombositopeni olan 80 gebe ile sağlıklı 80 gebenin fetal ve maternal sonuçları geriye dönük olarak dosya kayıtlarından incelendi. Bulgular:Trombositopeni etiyolojisi incelendiğinde en sık neden 31 hastada gestasyonel trombositopeni olarak değer lendirildi. Otuz dört hastada ağır preeklampsi, altı hastada eklampsi, iki hastada HELLP sendromu ve yedi hastada idi opatik trombositopenik purpura (ITP) izlendi. Trombositope nik gebelerin yaş ortalaması 29.41±5.48, kontrol grubunun 29.80±5.98 olarak saptandı (p 0.670). Trombositopenik ge belerde primer sezaryen oranı %48.75 (39/80) iken kontrol grubunda primer sezaryen oranı %23.75 (19/80) idi, bu sonuç istatistiksel olarak anlamlıydı (p

🔖

Cite This Article

ARTUNÇ, B. Ü., AKTENK, F., BAYTUR, Y. (2022). Feto-maternal outcomes of pregnancies with thrombocytopenia. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 25 - Sayı: 2, 89–94. https://ajindex.com/articles/571386

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. McCrae KR. Thrombocytopenia in pregnancy. Hematol ogy Am Soc Hematol Educ Program 2010;2010(1):397- 402. 2.Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, et al. Moderate to severe thrombocytope nia during pregnancy. Eur J Obstet Gynecol Reprod Biol 2006;128(1-2):163-8. 3.Shehata N, Burrows R, Kelton JG. Gestational thrombo cytopenia. Clin Obstet Gynecol 1999;42(2):327-34. 4.Provan D, Stasi R, Newland AC, Blanchette VS, Bolton- Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary im mune thrombocytopenia. Blood 2010;115(2):168-86. 5.McCrae KR. Thrombocytopenia in pregnancy: differen tial diagnosis, pathogenesis, and management. Blood Rev 2003;17(1):7-14. 6.Kam PC, Thompson SA, Liew AC. Thrombocytopenia in the parturient. Anaesthesia 2004;59(3):255-64. 7.Öztürk E, Atış A, Öçal P, Çepni İ, Madazlı R. İdiopatik trom bositopenide doğum şekli: 3 olgu sunumu. Cerrahpaşa Tıp Dergisi 2003;34(2):90-2. 8.Stavrou E, McCrae KR. Immune thrombocytope nia in pregnancy. Hematol Oncol Clin North Am 2009;23(6):1299-316. 9.Provan D, Newland A. Idiopathic thrombocytopenic pur pura in adults. J Pediatr Hematol Oncol 2003;25 Suppl 1:S34-8. 10.Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003;102(13):4306-11. 11.Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons JC, et al. Fetal platelet counts in thrombocytopenic pregnancy. Lancet 1990;336(8721):979-82. 12.Bussel JB, Druzin ML, Cines DB, Samuels P. Thrombocyto penia in pregnancy. Lancet 1991;337(8735):251. 13.Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329(20):1463-6. 14.Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000;79(9):744-9. 15.Kazandı M, Turan V, İtil İM. Gebelik ve trombositoopeni. J Turk Soc Obstet Gynecol 2010;7(4):247-50. 16.Gernsheimer TB. Thrombocytopenia in pregnancy: is this immune thrombocytopenia or.? Hematology Am Soc Hematol Educ Program 2012;2012(1):198-202.